-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Compass Pathways, Raises Price Target to $11

Benzinga·11/05/2025 18:04:54
Listen to the news
Morgan Stanley analyst Vikram Purohit maintains Compass Pathways (NASDAQ:CMPS) with a Overweight and raises the price target from $10 to $11.